In our study group, 37.5%, 61.60%, 58.92% and 20.53% of the ESCC tumours had p16, DAPK, GSTP1 and BRCA1 promoter methylation respectively, which was significantly higher than adjacent normal tissues. This evidence concerns the gene DAPK1 and neoplasm.